Sylvie Freeman

ORCID: 0000-0003-1869-180X

Colleges, School and Institutes

External positions

, Weatherall Institute of Molecular Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.

1 Oct 2017 → …
View graph of relations

Most downloaded publications

Assessment of Minimal Residual Disease in Standard-Risk AML
Robert Hills, Sylvie Freeman & 2 others, , 4 Feb 2016, In : The New England Journal of Medicine. 374, p. 422-433

Research output: Contribution to journal › Article

182 downloads
Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party
Sylvie Freeman & 4 others, , 12 Jan 2018, In : Blood.

Research output: Contribution to journal › Article

173 downloads
Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage
& 13 others, , Sylvie Freeman, Charles Craddock, 25 Jul 2016, In : The Journal of Experimental Medicine. 213, 8, p. 1513-35 23 p.

Research output: Contribution to journal › Article

162 downloads
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia
Robert Hills, Sylvie Freeman, 30 Sep 2016, In : Leukemia.

Research output: Contribution to journal › Article

155 downloads
Role of minimal (measurable) residual disease assessment in older patients with acute myeloid leukemia
Sylvie Freeman, 1 Jul 2018, In : Cancers. 10, 7, 15 p., 215.

Research output: Contribution to journal › Review article

108 downloads

Recent publications

Less is not necessarily more: toward a rational selection of the conditioning regimen in acute myeloid leukemia
Sylvie Freeman, 20 Apr 2020, In : Journal of Clinical Oncology . 38, 12, p. 1249-1251 3 p.

Research output: Contribution to journal › Editorial

Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting
Sylvie Freeman & 4 others, , 2 Apr 2020, In : British Journal of Haematology.

Research output: Contribution to journal › Article

Molecular MRD status and outcome after transplantation in NPM1-mutated AML
Robert Hills, Sylvie Freeman & 19 others, , Igor Novitzky Basso, 27 Feb 2020, In : Blood. 135, 9, p. 680-688 9 p.

Research output: Contribution to journal › Article

View all (44)